Serum adiponectin complexes and cardiovascular risk in children with chronic kidney disease
- PMID: 21553321
- PMCID: PMC3366590
- DOI: 10.1007/s00467-011-1906-x
Serum adiponectin complexes and cardiovascular risk in children with chronic kidney disease
Abstract
In contrast to the general population, patients with chronic kidney disease (CKD) experience increased total adiponectin levels despite an increased prevalence of cardiovascular disease. Adiponectin circulates as trimer, low molecular weight (LMW), and high molecular weight (HMW) complexes. The distribution and role of each subfraction in CKD is unknown. This cross-sectional analysis examined the association of serum adiponectin and its subfractions with known cardiovascular risk factors in 105 children (median age 12 years; 56% male) enrolled into the Chronic Kidney Disease in Children (CKiD) study, an observational cohort study of children with CKD stage 2-4.HMW accounted for 46% of total adiponectin, followed by LMW (34%) and trimer (20%). In multivariable analysis, LMW was independently associated with iohexol glomerular filtration rate (GFR) (p = 0.004) and was higher in pubertal versus prepubertal children (p = 0.005). HMW/LMW ratio was independently associated with age and iohexol GFR (all p < 0.001). Unexpectedly, systolic blood pressure was positively correlated with HMW (p = 0.01), and HMW/LMW ratio (p = 0.007) and inversely correlated with LMW (p = 0.009). Among subfractions, only LMW was significantly correlated with left ventricular mass (LVM) index (p = 0.05). In multivariable analysis, decreased LMW was independently associated with higher LVM index [β= -0.25, 95% confidence interval (CI) -0.50, -0.03, p=0.04) after adjustment for body mass index (BMI), age, and blood pressure.The higher total adiponectin levels in children with CKD are associated with higher HMW and lower LMW. This imbalance may be an important biomarker for increased cardiovascular risk despite higher levels of total adiponectin in children with CKD.
Figures



Similar articles
-
The proportion and metabolic effects of adiponectin multimeric isoforms in patients with chronic kidney disease on maintenance hemodialysis.Ren Fail. 2010;32(7):849-54. doi: 10.3109/0886022X.2010.494804. Ren Fail. 2010. PMID: 20662699
-
Adiponectin multimers, body weight and markers of cardiovascular risk in adolescence: Northern Ireland Young Hearts Project.Int J Obes (Lond). 2013 Sep;37(9):1247-53. doi: 10.1038/ijo.2012.214. Epub 2013 Jan 15. Int J Obes (Lond). 2013. PMID: 23318722
-
Changes in concentration of serum adiponectin multimeric forms following weight reduction programme in prepubertal obese children.Med Wieku Rozwoj. 2011 Jul-Sep;15(3):298-305. Med Wieku Rozwoj. 2011. PMID: 22006484
-
Preatherosclerosis and adiponectin subfractions in obese adolescents.Obesity (Silver Spring). 2008 Dec;16(12):2578-84. doi: 10.1038/oby.2008.439. Epub 2008 Oct 9. Obesity (Silver Spring). 2008. PMID: 18846045
-
Adiponectin in chronic kidney disease has an opposite impact on protein-energy wasting and cardiovascular risk: two sides of the same coin.Clin Nephrol. 2009 Aug;72(2):87-96. doi: 10.5414/cnp72087. Clin Nephrol. 2009. PMID: 19640365 Review.
Cited by
-
Adiponectin, driver or passenger on the road to insulin sensitivity?Mol Metab. 2013 Apr 19;2(3):133-41. doi: 10.1016/j.molmet.2013.04.001. Mol Metab. 2013. PMID: 24049728 Free PMC article. Review.
-
Isolation and quantitation of adiponectin higher order complexes.Methods Enzymol. 2014;537:243-59. doi: 10.1016/B978-0-12-411619-1.00013-6. Methods Enzymol. 2014. PMID: 24480350 Free PMC article.
-
Differential transendothelial transport of adiponectin complexes.Cardiovasc Diabetol. 2014 Feb 20;13:47. doi: 10.1186/1475-2840-13-47. Cardiovasc Diabetol. 2014. PMID: 24552349 Free PMC article.
-
New Insights into Adiponectin and Leptin Roles in Chronic Kidney Disease.Biomedicines. 2022 Oct 20;10(10):2642. doi: 10.3390/biomedicines10102642. Biomedicines. 2022. PMID: 36289903 Free PMC article. Review.
-
Adiponectin alters renal calcium and phosphate excretion through regulation of klotho expression.Kidney Int. 2017 Feb;91(2):324-337. doi: 10.1016/j.kint.2016.09.016. Epub 2016 Nov 30. Kidney Int. 2017. PMID: 27914707 Free PMC article.
References
-
- Ohashi K, Kihara S, Ouchi N, Kumada M, Fujita K, Hiuge A, Hibuse T, Ryo M, Nishizawa H, Maeda N, Maeda K, Shibata R, Walsh K, Funahashi T, Shimomura I. Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension. 2006;47:1108–1116. - PubMed
-
- Piñeiro R, Iglesias MJ, Gallego R, Raghay K, Eiras S, Rubio J, Diéguez C, Gualillo O, González-Juanatey JR, Lago F. Adiponectin is synthesized and secreted by human and murine cardiomyocytes. FEBS Lett. 2005;579:5163–5169. - PubMed
-
- Wang ZV, Scherer PE. Adiponectin, cardiovascular function, and hypertension. Hypertension. 2008;51:8–14. - PubMed
-
- Mallamaci F, Zoccali C, Cuzzola F, Tripepi G, Cutrupi S, Parlongo S, Tanaka S, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y. Adiponectin in essential hypertension. J Nephrol. 2002;15:507–511. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical